RLY-2608

Biorbyt

RLY-2608

10

Research Use Only

98.96%

C29H14ClF5N6O2

608.91

RLY-2608 is a selective mutant PI3Kalpha inhibitor that inhibits tumor growth in a PIK3CA mutant xenograft model.

N(C(=O)C1=CC(C(F)(F)F)=CC(F)=C1)C2=C3[C@@H](NC(=O)C3=CC(=C2)C4=C(C#N)N5C(C=C4)=NC=N5)C6=C(Cl)C=CC(F)=C6

-20°C

12352200